In race to COVID-19 drugs, EU may fast track remdesivir sale before U.S.

The European Union may give an initial green light in the coming days for sale of the drug remdesivir as a COVID-19 treatment, the head of its medicines agency said on Monday, fast-tracking the drug to market amid tight global competition for resources.

Source: Reuters: Health - May 18, 2020 Category: Consumer Health News Tags: healthNews Source Type: news